Literature DB >> 12118457

In vitro effect of antifungal drugs on pathogenic Naegleria spp.

Supathra Tiewcharoen1, Virach Junnu, Pisith Chinabut.   

Abstract

An ameba of the genus Naegleria causing fatal meningoencephalitis in human subjects was investigated for its sensitivity to antifungal drugs: amphotericin B, ketoconazole, fluconazole and itraconazole. The efficacy of these antifungal drugs for pathogenic Naegleria spp was investigated in three strains isolated from patients who had died of primary amebic meningoencephalitis infection at Siriraj Hospital (1986), Ramathibodi Hospital (1987) and Chachoengsao Hospital (1987). All of the isolates were maintained in axenic culture in the Department of Parasitology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand. The sensitivities of the antifungal drugs (MIC50) were: amphotericin B (0.05-0.5 microg/ml), ketoconazole (0.125 microg/ml), fluconazole (0.5-2.0 mg/ml), and itraconazole (10 mg/ml) (p < 0.05). It is important to explain that ketoconazole is slightly more effective than amphotericin B because its action is directed of the permeability of the amebic membrane. The amebae were more resistant ot fluconazole and itraconazole due to the action of the cytochrome P450 multienzyme (in the case of fluconazole) and the direct effect on heme-iron, blocking cytochrome P450-dependent chitin synthesis (in the case of itraconzole). We conclude that amphotericin B and ketoconazole remain the main drugs with proven activity against pathogenic Naegleria spp.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12118457

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  8 in total

1.  Successful treatment of an adolescent with Naegleria fowleri primary amebic meningoencephalitis.

Authors:  W Matthew Linam; Mubbasheer Ahmed; Jennifer R Cope; Craig Chu; Govinda S Visvesvara; Alexandre J da Silva; Yvonne Qvarnstrom; Jerril Green
Journal:  Pediatrics       Date:  2015-02-09       Impact factor: 7.124

Review 2.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

3.  Relaxed Substrate Requirements of Sterol 14α-Demethylase from Naegleria fowleri Are Accompanied by Resistance to Inhibition.

Authors:  Tatiana Y Hargrove; Zdzislaw Wawrzak; Girish Rachakonda; W David Nes; Fernando Villalta; F Peter Guengerich; Galina I Lepesheva
Journal:  J Med Chem       Date:  2021-11-29       Impact factor: 7.446

4.  Antiamoebic Properties of Metabolites against Naegleria fowleri and Balamuthia mandrillaris.

Authors:  Ruqaiyyah Siddiqui; Anania Boghossian; Bushra Khatoon; Muhammad Kawish; Ahmad M Alharbi; Muhammad Raza Shah; Hasan Alfahemi; Naveed Ahmed Khan
Journal:  Antibiotics (Basel)       Date:  2022-04-19

5.  Drug discovery for primary amebic meningoencephalitis: from screen to identification of leads.

Authors:  Anjan Debnath
Journal:  Expert Rev Anti Infect Ther       Date:  2021-03-11       Impact factor: 5.854

6.  Opportunistic free-living amoebal pathogens.

Authors:  Mohammad Ridwane Mungroo; Naveed Ahmed Khan; Sutherland Maciver; Ruqaiyyah Siddiqui
Journal:  Pathog Glob Health       Date:  2021-10-02       Impact factor: 3.735

7.  CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM).

Authors:  Anjan Debnath; Claudia M Calvet; Gareth Jennings; Wenxu Zhou; Alexander Aksenov; Madeline R Luth; Ruben Abagyan; W David Nes; James H McKerrow; Larissa M Podust
Journal:  PLoS Negl Trop Dis       Date:  2017-12-28

8.  A Search for Anti-Naegleria fowleri Agents Based on Competitive Exclusion Behavior of Microorganisms in Natural Aquatic Environments.

Authors:  Pichet Ruenchit; Narisara Whangviboonkij; Hathai Sawasdipokin; Uraporn Phumisantiphong; Wanpen Chaicumpa
Journal:  Pathogens       Date:  2021-02-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.